Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Inventory (2018 - 2025)

TransMedics has reported Inventory over the past 8 years, most recently at $48.9 million for Q4 2025.

  • Quarterly results put Inventory at $48.9 million for Q4 2025, up 5.0% from a year ago — trailing twelve months through Dec 2025 was $48.9 million (up 5.0% YoY), and the annual figure for FY2025 was $48.9 million, up 5.0%.
  • Inventory for Q4 2025 was $48.9 million at TransMedics, up from $44.5 million in the prior quarter.
  • Over the last five years, Inventory for TMDX hit a ceiling of $52.2 million in Q3 2024 and a floor of $11.8 million in Q1 2021.
  • Median Inventory over the past 5 years was $34.7 million (2023), compared with a mean of $31.9 million.
  • Biggest five-year swings in Inventory: skyrocketed 114.68% in 2023 and later dropped 20.14% in 2025.
  • TransMedics' Inventory stood at $14.9 million in 2021, then soared by 38.67% to $20.6 million in 2022, then skyrocketed by 114.68% to $44.2 million in 2023, then increased by 5.24% to $46.6 million in 2024, then increased by 5.0% to $48.9 million in 2025.
  • The last three reported values for Inventory were $48.9 million (Q4 2025), $44.5 million (Q3 2025), and $38.9 million (Q2 2025) per Business Quant data.